In psoriasis vulgaris, the link between inflammation and cerebrovascular events is increasingly being recognized, largely due to the role of cytokines such as interleukin-17 (IL-17) and interleukin-36 (IL-36). Here, IL17A is linked to psoriasis vulgaris.